Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 StudySofia Genta, Luca Ceriani, Luciano Cascione et al.|Cancers|2022Cited by 13